Smith+Nephew has signed a distribution agreement with SI-BONE for the iFuse TORQ pelvic fracture fixation portfolio.
The agreement is intended to broaden Smith+Nephew’s offerings for percutaneous pelvic fracture fixation procedures and to enhance its position in trauma care involving high-impact, high-frequency cases.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The iFuse TORQ portfolio includes the iFuse TORQ TNT and iFuse TORQ implants. These devices are indicated for pelvic fracture fixation and sacroiliac (SI) joint fusion.
iFuse TORQ TNT is designed to address bone density and anatomical requirements of the ilium and sacrum specifically.
The technology behind iFuse TORQ TNT has received the US Food and Drug Administration (FDA) breakthrough device designation for its potential to offer more effective treatment of pelvic fractures than traditional cannulated screws.
Additionally, it qualifies for a Medicare New Technology Add-on Payment (NTAP), providing hospitals with up to $4,136 in extra reimbursement per procedure using this device.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThrough this agreement, Smith+Nephew accesses the broader iFuse TORQ product line with SI-BONE’s existing sales channel. This move aims to better serve surgeons and patients in need of advanced pelvic fracture fixation options.
Smith+Nephew trauma, extremities and shoulder vice-president Scott Gunn said: “We’re incredibly excited to partner with SI-BONE. This collaboration reflects a shared commitment to innovation, clinical excellence, and improving patient outcomes.
“By combining SI-BONE’s industry leadership with Smith+Nephew’s established commercial platform, we see a meaningful opportunity to expand access to differentiated solutions, deepen surgeon engagement, and drive sustainable growth.”
Earlier this year, Smith+Nephew agreed to acquire Integrity Orthopaedics, a US-based developer of the Tendon Seam rotator cuff repair (RCR) system, for up to $450m.
Under the agreement, Smith+Nephew purchased Integrity Orthopaedics for an upfront cash payment of $225m, with additional performance-linked payments of up to $225m scheduled over the following five years.
